Literature DB >> 27765726

Trospium chloride is absorbed from two intestinal "absorption windows" with different permeability in healthy subjects.

Tobias Tadken1, Michael Weiss2, Christiane Modess1, Danilo Wegner1, Tarek Roustom1, Claudia Neumeister3, Ulrich Schwantes3, Hans-Ulrich Schulz4, Werner Weitschies5, Werner Siegmund6.   

Abstract

Intestinal P-glycoprotein is regio-selectively expressed and is a high affinity, low capacity efflux carrier for the cationic, poorly permeable trospium. Organic cation transporter 1 (OCT1) provides lower affinity but higher capacity for trospium uptake. To evaluate regional intestinal permeability, absorption profiles after gastric infusion of trospium chloride (30mg/250ml=[I]2) for 6h and after swallowing 30mg immediate-release tablets in fasted and fed healthy subjects, were evaluated using an inverse Gaussian density function to model input rate and mean absorption time (MAT). Trospium chloride was slowly absorbed (MAT ∼10h) after gastric infusion involving two processes with different input rates, peaking at about 3h and 7h. Input rates and MAT were influenced by dosage form and meal. In conclusion, trospium is absorbed from two "windows" located in the jejunum and cecum/ascending colon, whose uptake capacity might result from local abundance and functional interplay of P-glycoprotein and OCT1. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Food effects; Gastric infusion; OCT1; P-glycoprotein; Pharmacokinetics; Trospium chloride

Mesh:

Substances:

Year:  2016        PMID: 27765726     DOI: 10.1016/j.ijpharm.2016.10.030

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Empirical models for fitting of oral concentration time curves with and without an intravenous reference.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-02-01       Impact factor: 2.745

2.  Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin.

Authors:  Michael Weiss; David Z D'Argenio; Werner Siegmund
Journal:  Pharm Res       Date:  2022-09-26       Impact factor: 4.580

3.  Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug-Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect Models.

Authors:  Christian Wagner; Filippos Kesisoglou; Xavier J H Pepin; Neil Parrott; Arian Emami Riedmaier
Journal:  AAPS J       Date:  2021-06-17       Impact factor: 4.009

4.  Use of Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Drug-Food Interactions: an Industry Perspective.

Authors:  Arian Emami Riedmaier; Kevin DeMent; James Huckle; Phil Bransford; Cordula Stillhart; Richard Lloyd; Ravindra Alluri; Sumit Basu; Yuan Chen; Varsha Dhamankar; Stephanie Dodd; Priyanka Kulkarni; Andrés Olivares-Morales; Chi-Chi Peng; Xavier Pepin; Xiaojun Ren; Thuy Tran; Christophe Tistaert; Tycho Heimbach; Filippos Kesisoglou; Christian Wagner; Neil Parrott
Journal:  AAPS J       Date:  2020-09-27       Impact factor: 4.009

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.